Aller au contenu principal
Profil bibliographique

Qun Guo

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

60Publications signalées
2590Citations signalées
4Affiliations récentes

Les institutions déclarées

Les domaines associés

Air Quality and Health ImpactsCutaneous Melanoma Detection and ManagementSkin Protection and AgingClimate Change and Health ImpactsImmunotherapy and Immune Responses

Les publications récentes

Accès ouvert 2025 article OpenAlex

Sharp but consistent fungi species composition transition during a 40-yr urbanization in a subtropical city of China

Weimin Wang, Qun Guo, Wanyi Zhang, Liang Kou et autres

BACKGROUND: Rapid urbanization has profoundly impacted soil fungal dynamics and thus soil health, however, it remains poorly addressed due to lack of ideal experimental region. Taking Shenzhen of China, a megacity built within 30 years, as the study region, we analyzed the …

cn (code pays fourni par la source)

1 citation Environmental Microbiome
Accès ouvert 2025 article OpenAlex

Case Report: Kounis syndrome associated with urticaria following COVID-19 infection

Xia Li, Ailin Cao, Chengji Wang, Qun Guo et autres

This case report describes a 58-year-old woman who sought treatment in the dermatology department after experiencing a three-day episode of widespread rash and itching, along with fever, chills, abdominal distress, and increased urinary frequency and urgency. Upon examination, she exhibited numerous erythematous …

cn (code pays fourni par la source)

1 citation Frontiers in Cardiovascular Medicine
Accès ouvert 2024 article OpenAlex

IBI310 (anti-CTLA-4 antibody) monotherapy or in combination with sintilimab in advanced melanoma or urothelial carcinoma

Chuanliang Cui, Juan Li, Yue Yang, Lu Si et autres

IBI310 is a recombinant fully human IgG1 antibody against cytotoxic T lymphocyte antigen 4. This study was conducted to evaluate IBI310 monotherapy or combination therapy with sintilimab in the patients with advanced melanoma or urothelial carcinoma (UC). Patients in phase 1a received …

cn, Éthiopie, us (code pays fourni par la source)

4 citations The Innovation
Accès ouvert 2024 article OpenAlex

A phase Ib study evaluating the safety and efficacy of IBI310 plus sintilimab in patients with advanced non‐small‐cell lung cancer who have progressed after anti‐PD ‐1/ L1 therapy

Yuguang Zhao, Xiao Chen, Jun Yao, Jianlin Long et autres

BACKGROUND: The development of immune checkpoint inhibitors has made a significant breakthrough in the treatment of non-small-cell lung cancer (NSCLC). However, there remains a huge unmet clinical need for patients with acquired resistance after initial treatment response. METHODS: This study evaluated the …

cn, us (code pays fourni par la source)

6 citations Cancer Medicine
Accès ouvert 2022 erratum OpenAlex

Corrigendum: Chromosomal abnormalities and pregnancy outcomes for fetuses with gastrointestinal tract obstructions

Wu Xiaoqing, Linjuan Su, Qingmei Shen, Qun Guo et autres

INTRODUCTIONMATERIAL AND METHODSPatients and samplesTraditional karyotypingCMA platforms and data interpretationRESULTS The results of traditional karyotypingCMA results of 32 fetuses Clinical follow-upDISCUSSIONGRANT FUNDINGACKNOWLEDGEMENTSDISCLOSUREETHICS APPROVAL AND CONSENT TO PARTICIPATEAVAILABILITY OF DATA AND MATERIALREFERENCES

cn (code pays fourni par la source)

3 citations Frontiers in Pediatrics

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.